These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 14690338)

  • 1. Adjunctive high-dose intravenous immunoglobulin treatment for resistant atopic dermatitis: efficacy and effects on intracellular cytokine levels and CD4 counts.
    Jolles S; Sewell C; Webster D; Ryan A; Heelan B; Waite A; Rustin M
    Acta Derm Venereol; 2003; 83(6):433-7. PubMed ID: 14690338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome.
    Wakim M; Alazard M; Yajima A; Speights D; Saxon A; Stiehm ER
    Ann Allergy Asthma Immunol; 1998 Aug; 81(2):153-8. PubMed ID: 9723561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema.
    Weatherhead SC; Wahie S; Reynolds NJ; Meggitt SJ
    Br J Dermatol; 2007 Feb; 156(2):346-51. PubMed ID: 17223876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical improvement and immunohistochemical findings in severe atopic dermatitis treated with interferon gamma.
    Jang IG; Yang JK; Lee HJ; Yi JY; Kim HO; Kim CW; Kim TY
    J Am Acad Dermatol; 2000 Jun; 42(6):1033-40. PubMed ID: 10827410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
    Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
    J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First experience with enteric-coated mycophenolate sodium (Myfortic) in severe recalcitrant adult atopic dermatitis: an open label study.
    van Velsen SG; Haeck IM; Bruijnzeel-Koomen CA; de Bruin-Weller MS
    Br J Dermatol; 2009 Mar; 160(3):687-91. PubMed ID: 19120337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of severe atopic dermatitis with thymostimulin.
    Wisuthsarewong W; Viravan S
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S749-54. PubMed ID: 12403256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory cell numbers and cytokine expression in atopic dermatitis after topical pimecrolimus treatment.
    Simon D; Vassina E; Yousefi S; Braathen LR; Simon HU
    Allergy; 2005 Jul; 60(7):944-51. PubMed ID: 15932386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different cytokine production and activation marker profiles in circulating cutaneous-lymphocyte-associated antigen T cells from patients with acute or chronic atopic dermatitis.
    Antúnez C; Torres MJ; Mayorga C; Cornejo-García JA; Santamaría-Babi LF; Blanca M
    Clin Exp Allergy; 2004 Apr; 34(4):559-66. PubMed ID: 15080808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use.
    Paller AS; Eichenfield LF; Kirsner RS; Shull T; Jaracz E; Simpson EL;
    Pediatrics; 2008 Dec; 122(6):e1210-8. PubMed ID: 19015204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of CD25hiCD4+ "regulatory" T-cell subtypes in atopic dermatitis reveals a novel T(H)2-like population.
    Reefer AJ; Satinover SM; Solga MD; Lannigan JA; Nguyen JT; Wilson BB; Woodfolk JA
    J Allergy Clin Immunol; 2008 Feb; 121(2):415-422.e3. PubMed ID: 18177697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of intravenous immunoglobulin in the treatment of juvenile dermatomyositis: adverse reactions are associated with immunoglobulin A content.
    Manlhiot C; Tyrrell PN; Liang L; Atkinson AR; Lau W; Feldman BM
    Pediatrics; 2008 Mar; 121(3):e626-30. PubMed ID: 18299304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced dermal infiltration of cytokine-expressing inflammatory cells in atopic dermatitis after short-term topical tacrolimus treatment.
    Simon D; Vassina E; Yousefi S; Kozlowski E; Braathen LR; Simon HU
    J Allergy Clin Immunol; 2004 Oct; 114(4):887-95. PubMed ID: 15480330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of high-dose intravenous immunoglobulin treatment for atopic dermatitis.
    Jolles S
    Clin Exp Dermatol; 2002 Jan; 27(1):3-7. PubMed ID: 11952659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of atopic dermatitis with a combination of allergen-specific immunotherapy and a histamine-immunoglobulin complex.
    Nahm DH; Lee ES; Park HJ; Kim HA; Choi GS; Jeon SY
    Int Arch Allergy Immunol; 2008; 146(3):235-40. PubMed ID: 18268392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo levels of IL-4, IL-10, TGF-beta1 and IFN-gamma mRNA of the peripheral blood mononuclear cells in patients with alopecia areata in comparison to those in patients with atopic dermatitis.
    Katagiri K; Arakawa S; Hatano Y
    Arch Dermatol Res; 2007 Jan; 298(8):397-401. PubMed ID: 17021766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study.
    Bussmann C; Maintz L; Hart J; Allam JP; Vrtala S; Chen KW; Bieber T; Thomas WR; Valenta R; Zuberbier T; Sager A; Novak N
    Clin Exp Allergy; 2007 Sep; 37(9):1277-85. PubMed ID: 17845407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen specific cytokine response in pediatric patients with atopic dermatitis.
    Bordignon V; Sinagra JL; Trento E; Pietravalle M; Capitanio B; Cordiali Fei P
    Pediatr Allergy Immunol; 2005 Mar; 16(2):113-20. PubMed ID: 15787867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined therapy with low-dose omalizumab and intravenous immunoglobulin for severe atopic dermatitis. Report of four cases.
    Toledo F; Silvestre JF; Muñoz C
    J Eur Acad Dermatol Venereol; 2012 Oct; 26(10):1325-7. PubMed ID: 22050044
    [No Abstract]   [Full Text] [Related]  

  • 20. Low dose methotrexate therapy is effective in late-onset atopic dermatitis and idiopathic eczema.
    Zoller L; Ramon M; Bergman R
    Isr Med Assoc J; 2008 Jun; 10(6):413-4. PubMed ID: 18669134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.